MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Theravance/Glaxo’s Breo Ellipta wins FDA go-ahead

Theravance/Glaxo’s Breo Ellipta wins FDA go-ahead

By

Theravance/Glaxo's Breo Ellipta wins FDA go-ahead

GlaxoSmithKline (NYSE:GSK) and Theravance (NSDQ:THRX) won FDA approval for their co-developed Breo Ellipta inhaler for treatment of airflow obstructions, including bronchitis and emphysema in patients with chronic obstructive pulmonary disease.

The once daily, long-term maintenance inhaler is also indicated to reduce COPD exacerbations in patients with a history of such flare-ups, the companies said.

Breo Ellipta is a combination of the inhaled corticosteroid fluticasone furoate and the long-acting beta2 agonist vilanterol and is delivered to the patient using Theravance’s Ellipta, a new dry powder inhaler.

"The FDA approval of Breo Elipta brings an important inhaled, once-daily maintenance therapeutic option to COPD patients and doctors across the United States," Theravance CEO Rick Winningham said in a press statement. "After more than a decade of joint respiratory research and development, the approval is a very important milestone for Theravance and GSK."

Theravance and GlaxoSmithKline anticipate rolling out Breo Ellipta in the U.S. during the third quarter of fiscal 2013. Under previously set terms, FDA approval of Breo Ellipta obligates Theravance to make a milestone payment of $30 million to GSK.

The National Heart, Lung and Blood Institute estimates that as many as 27 million people in the US alone are affected by COPD, a number that is predicted to increase, the companies pointed out.

"This approval means that we can now realize our plan to bring Breo Ellipta to appropriate COPD patients in the U.S.," head of GSK Global Respiratory Franchise Darrell Baker said in a press statement. "We know that one of the main issues for patients who have experienced a COPD exacerbation is concern about possible future episodes. Breo Ellipta will help patients breathe better day-to-day and reduce the risk of future exacerbations, with a once-daily inhalation."

GlaxoSmithKline and Theravance are also seeking regulatory approval of the inhaler, under the trade name Relvar Ellipta, in Europe and Japan, the companies said.

In case you missed it

RSS From Medical Design & Outsourcing

  • How SpaceX is helping Medtronic prepare for the next pandemic wave
    As COVID-19 cases erupted around the globe earlier this year, Medtronic (NYSE:MDT) faced unprecedented demand for its ventilators. At first, Medtronic engineer Matt Phillips wasn’t sure how the company was going to supply enough ventilators to meet the surging global need. Then Elon Musk called with a proposal. Space Exploration Corporation (SpaceX), Elon Musk’s California-based company… […]
  • Could hydrogels and magnetic fields grow new cartilage?
    Researchers at the University of Pennsylvania are touting a new way to potentially rebuild complex body tissues to fix common injuries like cartilage degeneration. Following the publication of research in Advanced Materials, those involved are suggesting that the rebuilding process for these body tissues could be done by using a magnetic field and hydrogels, according to… […]
  • U of M researchers receive $6.6M to develop neuromod device for mental health
    Researchers at the University of Minnesota were last month awarded a $6.6 million grant to develop a device for treating mental health disorders. The National Institute of Mental Health provided the grant award in support of the development of a new medical device for treating those disorders by using brain rhythms, something that hasn’t been… […]
  • Stryker launches ‘smart’ hospital bed
    Stryker today announced the global launch of the industry’s first and only completely wireless hospital bed, ProCuity. ProCuity was designed to help reduce in-hospital patient falls at all acuity levels, improve nurse workflow and safety, and help lower hospital costs, according to Kalamazoo, Mich.-based Stryker. It is the only bed on the market today that… […]
  • 3M and Eko collaborate on stethoscopes
    3M (NYSE:MMM) and Eko announced today that they are collaborating to combine 3M’s Littmann stethoscope with Eko’s digital innovations. St. Paul, Minn.-based 3M’s new Littmann CORE digital stethoscope includes capabilities for clinicians to access both analog and digital auscultation options, along with amplification and noise cancellation and the visualization of sound during auscultation. 3M and Oakland,… […]
  • Henkel, Carbon expand 3D-printing partnership
    Henkel and Carbon today announced a partnership that will make Henkel’s single-component technologies immediately available to Carbon customers for use with Carbon’s additive manufacturing process. The agreement includes access to Henkel’s Loctite 3D IND405 clear resin, certified for Carbon’s Digital Light Synthesis (Carbon DLS) 3D-printing process. Loctite 3D IND405 may be used for enclosures and housings, light… […]
  • This surgeon developed an abdominal device to reduce hospital stays
    Many doctors have visualized devices to solve medical problems. The founder and CEO of Noleus Technologies has devised one to address prolonged hospital stays after abdominal surgery. As a practicing surgeon specializing in surgical oncology, colon and rectal surgery, Dr. Swarna Balasubramaniam had an idea over 20 years ago that she thought could make surgeons’… […]
  • Supply chain tool IDs COVID-19 supply shortages
    The American Society for Microbiology (ASM) has developed an online platform to identify COVID-19 and non-COVID testing supply shortages. In partnership with the Associaton for Supply Chain Management (ASCM), ASM developed the platform to identify and monitor the testing supplies to be made aware of shortages in real-time, according to a news release. Get the… […]
  • Saraca Solutions seeks to slash clinical evaluation report times
    Saraca Solutions announced today that it has developed a tracking tool to reduce the time it takes to create an update for a clinical evaluation report (CER). A CER documents conclusions for a medical device’s clinical evaluation. It consists of analyzed clinical data collected from either investigation of a company’s device or studies of substantially… […]
  • These small companies are making big COVID-19 contributions
    Major companies continue grabbing the headlines around the COVID-19 pandemic, but smaller companies have contributed their share toward helping patients, boosting research and keeping frontline workers safe. This week, Minnesota’s Medical Alley Association issued a report on its members’ pandemic responses, including companies large and small, from telehealth providers to a tube-feeding company. We wanted… […]
  • Schurter adds switch for harsh environments
    Schurter recently debuted a piezoelectric switch, PSE, which is installation-ready with its pre-assembled 15-meter-long cable. The potted polyurethane cable offers installation flexibility with the highest IP67 protection according to IEC 60529 and IP69K according to DIN 40050-9, according to the company. Designed to be waterproof from its surface to its electrical connections the switch’s housing… […]

Leave a Reply